The Methodist Hospital System. Leading Medicine
The Methodist Hospital System. Leading Medicine

Methodist Center for Liver Disease & Transplantation

About Us

The liver transplant program within the Methodist Transplant Center is characterized by close coordination between hepatologists—the liver specialists who refer most liver transplant patients to the transplant center—and the surgeons, nurses, transplant coordinators, dieticians and other staff within the transplant center.

Referral and evaluation

Acute, irreversible liver disease has numerous causes. This include untreated Hepatitis B or Hepatitis C infection, cancer of the liver, non-alcoholic fatty liver disease (NAFLD), alcoholic cirrhosis of the liver, and a number of hereditary liver disorders as well. Regardless of the cause, however, every patient who is referred to the liver transplant program begins with a comprehensive health evaluation, including tests of liver function, diagnostic scans, and overall health evaluation. Once testing is complete, the patient’s record and results are reviewed in conference, to determine if the patient is a candidate for transplantation.

Exceptional staff, exceptional resources

The liver transplant program is distinguished by the expertise and experience of the surgeons and hepatologists on the staff, as well as by the skill and dedication of the multidisciplinary team that works with the patients every day. Highly advanced surgical and outpatient facilities are another significant point of differentiation, with the Methodist Transplant Program a strong focus for infrastructure investment at the hospital.

Innovation

The liver transplant program offers a wide range of liver transplant surgeries, including whole-organ, live-donor and split-liver transplants. The latter procedures, while both rare and complex, represent important options for patients, and help to set the Methodist Transplant Center apart from transplant programs at other hospitals.

Research

Physicians and scientists within the liver transplant program are actively involved in research into new forms of immunosuppression, strategies for reducing complications, and new ways to fight post-operative infection. This research includes projects underway in the laboratory, as well as clinical trials that can represent new and experimental treatments for qualifying patients.

Click the image above to zoom